Background: Various megaprostheses are currently available for reconstruction of the proximal femur after tumor resection. This study evaluates the survival and complications of a modular megaprosthesis for reconstruction of the proximal femur.

Materials And Methods: We studied the medical files of 109 tumor patients (age range 16-86 years) who underwent proximal femoral reconstruction with the MRP(®) megaprosthesis from 2002 to 2011. There were 70 patients with metastases, 34 patients with bone sarcomas, and five patients with hematological malignancies; 82 were primary and 27 were revision reconstructions. Mean follow-up was 2.5 years; 31 patients had a minimum five-year follow-up. We evaluated the survival and function of the patients, and the survival and complications of the megaprostheses.

Results: Survival was significantly higher for the patients with bone sarcomas compared to those with metastases and hematological malignancies. Mean MSTS functional score was similar between patients with bone sarcomas and those with hematological malignancies and metastases, and between patients with primary and those with revision reconstructions. Overall survival of the MRP(®) megaprostheses was 74 % at 5 and 9 years. Fourteen (13.6 %) major complications occurred at a mean period of 1.4 years (range 3 months to 4.5 years); these included infection (5.8 %), dislocation (3.9 %), local recurrence (2.9 %), and acetabular fracture (1 %).

Conclusion: MRP(®) megaprostheses are a valuable reconstruction option after tumor resection of the proximal femur.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00590-016-1764-0DOI Listing

Publication Analysis

Top Keywords

reconstruction proximal
12
proximal femur
12
patients bone
12
bone sarcomas
12
hematological malignancies
12
patients
9
tumor resection
8
survival complications
8
metastases patients
8
primary revision
8

Similar Publications

Introduction And Importance: A terminal extensor tendon disruption, with or without bony avulsion, may lead to a mallet deformity. In most cases, trauma precedes deformity. Non-traumatic causes are less probable.

View Article and Find Full Text PDF

Real-time dose reconstruction in proton therapy from in-beam PET measurements.

Phys Med Biol

March 2025

Grupo de Física Nuclear & IPARCOS, Universidad Complutense de Madrid, Facultad de CC. Físicas, Avda. Complutense s/n, Madrid, 28040, SPAIN.

Clinical implementation of in-beam PET monitoring in proton therapy requires the integration of an online fast and reliable dose calculation engine. This manuscript reports on the achievement of real-time reconstruction of 3D dose and activity maps with proton range verification from experimental in-beam PET measurements. Approach: Several cylindrical homogeneous PMMA phantoms were irradiated with a monoenergetic 70-MeV proton beam in a clinical facility.

View Article and Find Full Text PDF

Introduction: The obesity epidemic is especially common among the elderly population. As the majority of patients with proximal humeral fractures undergoing a reverse shoulder arthroplasty (RSA) are elderly, it is essential to understand how obesity can impact the outcomes of shoulder arthroplasty in this patient group. However, there is limited consensus on the functional outcome measures and range of motion in obese patients undergoing RSA for fractures compared to non-obese patients.

View Article and Find Full Text PDF

Introduction: This study aimed to compare the clinical outcomes of cemented versus cementless reverse total shoulder arthroplasty (rTSA) for the treatment of proximal humeral fractures (PHFs), with a focus on revision rates, tuberosity union, scapular notching, range of motion, and functional scores.

Materials And Methods: A systematic review and meta-analysis were conducted, incorporating data from studies comparing cemented and cementless rTSA for PHFs. Key outcomes analyzed included revision rates, tuberosity union rates, scapular notching, range of motion, and functional scores.

View Article and Find Full Text PDF

Purpose: The proximal femur is a frequent site of cancer dissemination in the extremities. Patients treated surgically for skeletal metastases have poorer overall health compared to other orthopedic patients, with only one-third expected to survive two years post-surgery. Choosing a treatment that minimizes revision risk and ensures the implant outlives the patient is therefore crucial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!